Analysts say DSM's potential is underestimated

It seems DSM 's stock trades with a discount. Most of the analysts say DSM is cheap at this level. Currently the company is being followed by 18 researchers. The recommendations are: 1 times sell, 2 times hold and no buys. The average of the current target prices for the stock equals 99,86 euros. This is around 32 percent more than the current price of 75,52 euros. The most recent recommendations for the chemical company are from Macquarie Research, Barclays and Berenberg.

Fair values for DSM vary a lot

Based on the current number of shares DSM 's market capitalization equals 13,22 billion euros. The DSM stock was the past 12 months quite unstable. Since last December the stock is 4 percent lower. This year the stock price moved between 73 and 93 euro. Since 2008 the stock price is almost 351 percent higher.

Historical stock prices DSM

At 12.05 the stock trades 0,16 percent higher at 75,52 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.